[1] ZENG XF, CHEN YL, CHEN JW, et al.2018 Chinese guideline for the diagnosis and treatment of rheumatoid arthritis[J]. Chinese Journal of Internal Medicine(中华内科杂志), 2018, 57(4): 242-250. [2] EMERY P, BREEDVELD FC, LEMMEL EM, et al.A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis[J]. Rheumatology, 2000, 39(6): 655-665. [3] SAAG KG, TENG GG, PATKAR NM, et al.American college of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. American College of Rheumatology[J]. Arthritis Rheum, 2008, 59(6): 762-770. [4] US Food & drug administration, FDA Drug Safety Communication: New boxed warning for severe liver injury with arthritis drug Arava (leflunomide) [EB/OL]. (2010-09-09)[2010-01-01]. http://fda.gov/Drugs/DrugSafety/Postmarket Drug Safety Information for Patients and Providers/ucm218679.htm. [5] Cancer Biomedical Informatics Grid. Unified Medical Language System[EB/OL]. ( 2018-05-04)[2020-03-24]. https://bioportal. bioontology.org/ontologies/MEDDRA. [6] MO GX.Review the research and practice of measures of dispropo-rtionality in pharmacovigilance in China[J]. Chinese Journal of Drug Evaluation(中国药物评价), 2015, 32(2): 118-121. [7] ZHANG LM, PEI ZE.Analysis on the status Quo of drug risk manage-ment in China from the leflunomide event[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2008, 5(1): 3-7. [8] VAN ROON EN, JANSEN TL, HOUTMAN NM, et al.Leflunomide for the treatment of rheumatoid arthritis in clinical practice: incidence and severity of hepatotoxicity[J]. Drug Saf, 2004, 27(5): 345-352. [9] BIRD P, GRIFFITHS H, TYMMS K, et al.The SMILE study - safety of methotrexate in combination with leflunomide in rheumatoid arthritis[J]. J Rheumatol, 2013, 40: 228-235. [10] SINGH JA, SAAG KG, BRIDGES SL JR, et al.2015 american college of rheumatology guideline for the treatment of rheumatoid arthritis[J]. Arthritis Care Res , 2016, 68(1): 1-25. [11] STRAND V, COHEN S, SCHIFF M, et al.Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate[J]. Leflunomide Rheumatoid Arthritis Investigators Group. Arch Intern Med, 1999, 159(21): 2542-2550. [12] JIN S, LI M, FANG Y, et a1.Chinese registry of rheumatoid arthritis(CREDIT):II.prevalence and risk factors of major comorbidities in Chinese patients with rheumatoid arthritis[J].Arthritis Res Ther, 2017, 19(1): 251-258. [13] SU R, WEI L, CHEN YC, et al.Efficacy and safety of leflunomide and methotrexate in treating rheumatoid arthritis: a meta-analysis[J]. Chinese Journal of Evidence-Based Medicine(中国循证医学杂志), 2011, 11(9): 1062-1069. [14] BIRD P, GRIFFITHS H, TYMMS K, et al.The SMILE study-safety of methotrexate in combination with leflunomide in rheumatoid arthritis[J]. J Rheumatol, 2013, 40(3): 228-235. [15] CURTIS JR, BEUKELMAN T, ONOFREI A, et al.Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide[J]. Ann Rheum Dis, 2010, 69(1): 43-47. |